Genetics at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

18 organizations at AMP 2026 present work in genetics: 16 academic medical centres, children's hospitals and universities, 1 clinical laboratory and 1 public organization. Between them they bring 62 presentations to the program. Most represented: Mayo Clinic (11 on the program), Memorial Sloan Kettering Cancer Center (5 on the program), Johns Hopkins University School of Medicine (3 on the program). 18 of them have their own page in this guide. As of Sep 25, 2026.

All 298 organizations at AMP 2026 →

Showing 1–8 of 18 organizations

Organization	AMP 2026 Attendance
Mayo Clinic Rochester, MN
mayoclinic.org Med centres Academic medical center and health system whose laboratories develop and run clinical molecular and genomic testing.	Workshop Wed, Nov 11 12:00pm–12:50pm Genome as a Platform: Advancing MRD Research with Illumina Whole Genome Sequencing Oncology Prep Whole-genome sequencing as a single platform for molecular residual disease research, with early analytical performance data. Workshop hosted by Illumina Skagit 5, Lower Level, Arch at 800 Pike Talk Thu, Nov 12 10:45am–11:15am Part of Clinical Applications of Transcriptomics in Lymphomas and Leukemias New Insights from Gene Expression Profiling of Anaplastic Large Cell Lymphoma 608-609, Level 6, Arch at 705 Pike Hematopathology Plenary Thu, Nov 12 1:15pm–2:15pm Part of Solid Tumors Plenary Session DNA Methylation and Artificial Intelligence for the Diagnosis and Classification of CNS Tumors Ballroom ABC, Level 6, Arch at 705 Pike Solid Tumors Talk Fri, Nov 13 10:15am–10:35am Part of Technologist Innovation Session TT009 Assessment of X-Chromosome Inactivation Using Oxford Nanopore Technologies (ONT) Long-Read Sequencing 602-604, Level 6, Arch at 705 Pike Technologist Innovation Session Talk Fri, Nov 13 10:35am–10:55am Part of Technologist Innovation Session ID024 Evaluation of a Targeted Metagenomics Kit for Microbial Identification Using the V1-V2 Region of the 16S Ribosomal RNA Gene 602-604, Level 6, Arch at 705 Pike Technologist Innovation Session Session Fri, Nov 13 1:15pm–2:45pm Clinical Application of Long-read Sequencing Ballroom E, Level 6, Arch at 705 Pike Genetics 1:15pm–1:45pmFully Integrated SNV, Fusion, and Isoform Analysis of Cancer Drivers with Long-read RNA-seq for Improved Functional InterpretationUniversity of California, Santa Cruz 1:45pm–2:15pmImproving Long-Read Sequencing for Transcriptome and Amplicon Sequencing ApplicationsUniversity of California, Santa Cruz 2:15pm–2:45pmClinical Implementation of Long-Read Sequencing: From Targeted Assays to Genome SequencingStanford University School of Medicine Poster Fri, Nov 13 7:45am–8:00am Part of Platform Presentations of Selected HemePath Abstracts I H041 Validation and Clinical Application of Comprehensive DNA and RNA NGS for Measurable Residual Disease Assessment of Myeloid Neoplasms Talk Sat, Nov 14 10:15am–10:45am Part of Current and Emerging Methods for Structural Variants and Gene Fusions FISH vs. RNA sequencing for Structural Variant Detection in Solid Tumors: Strengths and Limitations Case-based comparison of break-apart FISH and RNA sequencing for finding gene rearrangements in solid tumors, including FFPE pitfalls. 611-614, Level 6, Arch at 705 Pike Hematopathology · Lab Management · Solid Tumors Session Sat, Nov 14 10:15am–11:45am Foundation Models in Molecular 608-609, Level 6, Arch at 705 Pike Informatics 10:15am–11:00amFrom AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing?The University of Texas MD Anderson Cancer Center 11:00am–11:45amA Bioinformatician's Guide to Choosing Biological Foundation Models in 2026 Poster Sat, Nov 14 2:00pm–2:15pm Part of Platform Presentations of Selected Genetics Abstracts II G075 UGT1A1 Genotyping for Pharmacogenomics Testing: Is Sequencing Necessary? 608-609, Level 6, Arch at 705 Pike Talk Sat, Nov 14 2:30pm–3:00pm Part of Interactive Visualization Tools for Molecular Testing CNVpytor: Comprehensive Detection, Annotation, and Visualization of Germline and Somatic Copy Number Variations CNVpytor, a tool combining read depth and B-allele frequency to call and visualize germline and somatic copy number changes. 606-607, Level 6, Arch at 705 Pike Informatics Poster Sat, Nov 14 7:30am–7:45am Part of Platform Presentations of Selected Solid Tumors Abstracts I ST094 MET Exon 14 Skipping Discordance as a Tool for Quality Improvement in Clinical NGS Testing
Memorial Sloan Kettering Cancer Center New York, NY
mskcc.org Med centres Cancer hospital and research institute in New York with a large clinical tumour sequencing and molecular diagnostics programme.	Session Thu, Nov 12 1:15pm–2:15pm Solid Tumors Plenary Session Ballroom ABC, Level 6, Arch at 705 Pike Solid Tumors 1:15pm–2:15pmDNA Methylation and Artificial Intelligence for the Diagnosis and Classification of CNS TumorsMayo Clinic Talk Thu, Nov 12 2:30pm–3:00pm Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting AMP Clinical Validation of cfDNA and ctDNA Assays Working Group Setting validation standards for liquid biopsy assays in oncology, with attendee input shaping the guideline under development. Ballroom E, Level 6, Arch at 705 Pike Talk Thu, Nov 12 3:00pm–3:30pm Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting AMP Copy Number Alterations Working Group Copy number alterations called from sequencing: how those assays are validated, reported and read next to FISH, cytogenetics and microarray. Ballroom E, Level 6, Arch at 705 Pike Workshop Thu, Nov 12 4:25pm–4:55pm Want to get involved with AMP? Volunteering pathways in the professional society, from short time-limited tasks through committee membership and leadership roles. Innovation Spotlight Stage #3 Session Fri, Nov 13 10:15am–11:45am Accelerating the Impact of Molecular Profiling in Pediatric and Adolescent Young Adult (AYA) Tumors Ballroom E, Level 6, Arch at 705 Pike Hematopathology · Solid Tumors 10:15am–11:00amFrom Profiling to Clinical Impact: Advancing Molecular Diagnostics for Pediatric and AYA CancersBoston Children's Hospital/ Dana Farber Cancer Institute 11:00am–11:45amPresentation Title TBD Talk Fri, Nov 13 11:15am–11:45am Part of Resolving the Unknown: Functional and Computational Approaches to Determine Pathogenicity of Genetic Variants AlphaMissense for Identifying Pathogenic Missense Mutations in DNA Damage Repair Genes in Cancer Using AlphaMissense and related AI tools to flag pathogenic missense variants in DNA damage repair genes in cancer. 611-614, Level 6, Arch at 705 Pike Genetics Talk Fri, Nov 13 1:15pm–2:45pm Part of Optimizing Computational Infrastructure for High-throughput Clinical Data Data Analysis, Interpretation, and Discovery in 100,000 Patients With Cancer Combining somatic, germline and clinical data from over 100,000 cancer patients to support variant interpretation, trials and discovery. 611-614, Level 6, Arch at 705 Pike Informatics Session Sat, Nov 14 10:15am–11:45am Update on the Role of CtDNA-Based Detection of MRD in Clinical Trials and Beyond for Solid Tumors Ballroom E, Level 6, Arch at 705 Pike Solid Tumors 10:15am–11:00amMinimal Residual Disease in Colorectal Cancer: Opportunities for therapeutic developmentThe University of Texas MD Anderson Cancer Center, Houston, TX 11:00am–11:45amLiquid Biopsy Biomarkers for Early Detection of Treatment Response and Disease MonitoringMCGill University, Research Institute of the McGill University Health Centre Session Sat, Nov 14 1:15pm–2:15pm Platform Presentations of Selected Solid Tumor Abstracts II 611-614, Level 6, Arch at 705 Pike 1:15pm–1:30pmST026 Comparative Analysis of Copy Number Variant Detection from DNA Methylation Arrays Against Targeted Next-Generation Sequencing in a Pan-Cancer CohortNYU Langone Health 1:30pm–1:45pmST074 Integration of Longitudinal ctDNA Sequencing and Quantitative ESR1 Mutation Analysis to Inform Molecular Monitoring Strategies in Metastatic Breast CancerEarle A Chiles Research Institute, Providence Health 1:45pm–2:00pmST015 Clinical Evaluation of Whole Genome Enzymatic Methylation Sequencing for Integrated Classification and Copy Number Profiling of Pediatric Central Nervous System TumorsChildren's Hospital Los Angeles, University of Southern California 2:00pm–2:15pmST093 Tumor Cellularity Limits Next-Generation Sequencing Sensitivity for MTAP Loss: Post-Validation Next-Generation Sequencing-Immunohistochemistry Concordance in a Large Single-Institution CohortM.D. Anderson Cancer Center
Johns Hopkins University School of Medicine Baltimore, MD
hopkinsmedicine.org Med centres Medical school and teaching hospital in Baltimore with research on cell-free DNA fragmentation and early cancer detection.	Talk Thu, Nov 12 10:15am–11:00am Part of Computational Analysis of Fragmentation and Methylation Patterns in ctDNA for Early Cancer Detection Bespoke Cell-free DNA Fragmentation Biomarkers for Early Cancer Detection Cell-free DNA fragmentation features for early cancer detection, and the study design needed with small cohorts and huge data. 611-614, Level 6, Arch at 705 Pike Informatics Session Thu, Nov 12 10:15am–11:45am Multimodal Deep Learning to Supercharge Polygenic Risk Scores: From Research Breakthroughs to Molecular Diagnostics Implementation 606-607, Level 6, Arch at 705 Pike Genetics 10:15am–10:45amGenetically Anchored Protein Networks: Mapping Inherited Risk onto Brain BiologyUniversity of California, Davis 10:45am–11:15amPopulation Genetics in an Era of Genomic HealthIcahn School of Medicine at Mount Sinai 11:15am–11:45amBeyond Single-Modality Genomic Risk AssessmentYale University School of Medicine Session Thu, Nov 12 5:00pm–6:00pm Genetics Plenary Session Ballroom ABC, Level 6, Arch at 705 Pike Genetics 5:00pm–6:00pmData, Deep Learning, and Decision-Making: AI in Precision Medicine and GenomicsNational Human Genome Research Institute Workshop Sat, Nov 14 12:00pm–12:30pm AMP Innovates Meet the Authors Series: WHO/ICC Perspectives How genomic findings feed the WHO and ICC classifications of myeloid neoplasms, and what that means for treatment. Innovation Spotlight Stage #2 Session Sat, Nov 14 1:15pm–2:15pm Platform Presentations of Selected Genetics Abstracts II 608-609, Level 6, Arch at 705 Pike 1:15pm–1:30pmG065 Fully Automated 1–50 mL Plasma and Urine cfDNA Sample Preparation for Liquid Biopsy ApplicationsnRichDX 1:30pm–1:45pmG040 Towards a Comprehensive Picture of HRR: Multicentre Validation of MS-digitalMLPA for Copy Number and Methylation Assessment in Somatic FFPE and Germline SamplesMRC Holland 1:45pm–2:00pmG005 Beyond the Karyotype: A Multi-Platform Approach to Unraveling Constitutional Structural Variants Using Long-Read Sequencing, Optical Genome Mapping, and 3D Chromatin ArchitectureThe Johns Hopkins University School of Medicine 2:00pm–2:15pmG075 UGT1A1 Genotyping for Pharmacogenomics Testing: Is Sequencing Necessary?Mayo Clinic Poster Sat, Nov 14 1:45pm–2:00pm Part of Platform Presentations of Selected Genetics Abstracts II G005 Beyond the Karyotype: A Multi-Platform Approach to Unraveling Constitutional Structural Variants Using Long-Read Sequencing, Optical Genome Mapping, and 3D Chromatin Architecture 608-609, Level 6, Arch at 705 Pike Session Sat, Nov 14 2:30pm–4:00pm Unmasking Hidden Drivers: Advances in Detection and Interpretation of Structural Variants in Precision Medicine Ballroom E, Level 6, Arch at 705 Pike Genetics 2:30pm–3:00pmA Clearer View of Structural Variation: The Role of Optical Genome Mapping in Genetic Disease and Pediatric Cancer DiagnosticsCincinnati Children's Medical Center 3:00pm–3:30pmPutting Long-Read Sequencing to Work: Practical Approaches for the ClinicJohns Hopkins University Talk Sat, Nov 14 5:15pm–5:30pm Closing Remarks
University of California San Francisco San Francisco, CA
ucsf.edu Med centres Public health sciences university in San Francisco with clinical laboratories and research in genomics and molecular diagnostics.	Talk Thu, Nov 12 11:15am–11:45am Part of Clinically Actionable Mutational Signatures in Solid Tumors Novel Mutational Signatures in Cancer Two newly described mutational signatures, one tied to antiretroviral drugs and one to aristolochic acid. Ballroom E, Level 6, Arch at 705 Pike Solid Tumors Workshop Thu, Nov 12 3:45pm–4:15pm Optimized Automated Extraction for FFPE Tissue Cores Automated simultaneous DNA and RNA extraction from FFPE cores and sections, validated for sequencing-grade yield. Workshop hosted by Covaris Innovation Spotlight Stage #1 Talk Sat, Nov 14 10:45am–11:15am Part of Prenatal Genetic Sequencing: Diagnostic Yield, Incidental Findings and Addressing Uncertainty Diagnostic Yield of Prenatal Genomic Sequencing Diagnostic yield of exome and genome sequencing for fetal anomalies, including variants of uncertain significance. 606-607, Level 6, Arch at 705 Pike Genetics Poster Sat, Nov 14 1:45pm–2:00pm Part of Platform Presentations of Selected Informatics Abstracts II I041 GPU-Accelerated Alignment and Variant Calling in Cancer Panel Sequencing: A Head-to-Head Benchmarking Study Against a Standard CPU Pipeline in a Real-World Dataset 602-604, Level 6, Arch at 705 Pike Poster Sat, Nov 14 7:15am–7:30am Part of Platform Presentations of Selected Solid Tumors Abstracts I ST068 Methylomic Stratification of Recurrence Risk in Primary, Low-Grade, Copy Number-Low Endometrioid Adenocarcinoma of the Uterus
Children's Hospital of Philadelphia Philadelphia, PA
chop.edu Pediatric Pediatric academic medical center and research institute in Philadelphia.	Workshop Fri, Nov 13 12:00pm–12:30pm AMP Practice Guidelines Meet the Authors Series: AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer Update Forthcoming updates to somatic variant reporting standards, covering the four tiers, liquid biopsy and clonal haematopoiesis. Innovation Spotlight Stage #3 Talk Sat, Nov 14 11:15am–11:45am Part of Prenatal Genetic Sequencing: Diagnostic Yield, Incidental Findings and Addressing Uncertainty Genome Sequencing as a First-Tier Prenatal Diagnostic Test: Results from a Prospective Blinded Study Prospective blinded comparison of prenatal genome sequencing against karyotype and chromosomal microarray in invasive testing. 606-607, Level 6, Arch at 705 Pike Genetics
Johns Hopkins University Baltimore, MD
jhu.edu Med centres Private research university in Baltimore with medical school work on cancer genetics, cell-free DNA and molecular diagnostics.	Talk Fri, Nov 13 1:15pm–2:00pm Part of Menin Inhibitors and Targeted Therapy Resistance in AML Menin Inhibitor Use in Acute Myeloid Leukemia Current evidence for menin inhibition in acute myeloid leukemia, approved and investigational drugs, and residual disease monitoring. 608-609, Level 6, Arch at 705 Pike Hematopathology Talk Sat, Nov 14 3:00pm–3:30pm Part of Unmasking Hidden Drivers: Advances in Detection and Interpretation of Structural Variants in Precision Medicine Putting Long-Read Sequencing to Work: Practical Approaches for the Clinic Practical long-read sequencing for structural variants across large cohorts, targeted enrichment and difficult clinical samples. Ballroom E, Level 6, Arch at 705 Pike Genetics
Lurie Children's Hospital of Chicago Chicago, IL
luriechildrens.org Pediatric Pediatric hospital in Chicago affiliated with Northwestern University Feinberg School of Medicine.	Workshop Wed, Nov 11 12:00pm–12:50pm Beyond Fusion Detection: Scalable RNA-Based Tumor Profiling for Molecular Classification RNA sequencing of tumours for fusion detection and expression-based classification, run through automated library prep. Workshop hosted by Agilent Technologies Tahoma 5, Level 3, Arch at 800 Pike Session Sat, Nov 14 2:30pm–4:00pm Unmasking Hidden Drivers: Advances in Detection and Interpretation of Structural Variants in Precision Medicine Ballroom E, Level 6, Arch at 705 Pike Genetics 2:30pm–3:00pmA Clearer View of Structural Variation: The Role of Optical Genome Mapping in Genetic Disease and Pediatric Cancer DiagnosticsCincinnati Children's Medical Center 3:00pm–3:30pmPutting Long-Read Sequencing to Work: Practical Approaches for the ClinicJohns Hopkins University
Oregon Health & Science University Portland, OR
ohsu.edu Med centres Public health sciences university and academic medical centre in Portland with clinical genetics and cancer genomics programmes.	Workshop Wed, Nov 11 8:00am–8:50am Decentralized precision testing: AI, Gene Signatures, and Rapid Biomarker Testing in real world settings Rapid biomarker testing and AI tools deployed in community health systems alongside academic cancer centres. Workshop hosted by Biocartis Tahoma 5, Level 3, Arch at 800 Pike Session Sat, Nov 14 10:15am–11:45am Prenatal Genetic Sequencing: Diagnostic Yield, Incidental Findings and Addressing Uncertainty 606-607, Level 6, Arch at 705 Pike Genetics 10:15am–10:45amNoninvasive Prenatal Screening for Mendelian Disorders: Clinical Opportunities and ChallengesBaylor Genetics, Baylor College of Medicine 10:45am–11:15amDiagnostic Yield of Prenatal Genomic SequencingUCSF 11:15am–11:45amGenome Sequencing as a First-Tier Prenatal Diagnostic Test: Results from a Prospective Blinded StudyThe Children’s Hospital of Philadelphia